Literature DB >> 25282632

Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.

Tau Ming Liew1, Lei Feng2, Qi Gao2, Tze Pin Ng2, Philip Yap3.   

Abstract

OBJECTIVES: The Montreal Cognitive Assessment (MOCA) is a screening tool for mild cognitive impairment (MCI) and dementia. The new criteria for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) mild neurocognitive disorder (NCD) define participants with cognitive decline but no dementia, and major NCD (dementia). We explored the usefulness of MOCA to detect major and mild NCD.
DESIGN: Cross-sectional test research.
SETTING: Tertiary hospital memory clinic and community-based Singapore Longitudinal Aging Study (SLAS). PARTICIPANTS: Participants with questionable dementia (clinical dementia rating, CDR = 0.5) and early dementia (CDR ≤1) over a period of 1 year were identified from the memory clinic registry. The patient records were reviewed and the diagnostic labels of major and mild NCD were applied accordingly. Healthy controls (HC) (CDR = 0, Mini-Mental State Examination >26) were recruited from the on-going SLAS. MEASUREMENTS: Major and mild NCD were diagnosed based on medical history, clinical examination, basic and instrumental activities of daily living, locally validated bedside cognitive tests (Mini-Mental State Examination, Frontal Assessment Battery, and Clock Drawing Test), relevant laboratory investigations and standardized neuropsychological assessment.
RESULTS: Two hundred fifty-one participants were included (41 mild NCD, 64 major NCD, 146 HC). On receiver operating characteristic curve analysis, the diagnostic performance by area under the curve (AUC) for MOCA was 0.99 [95% confidence interval (CI) 0.98-1.0] for major NCD and 0.77 (95% CI 0.67-0.86) for mild NCD. For diagnosis of mild NCD, MOCA performed better in those with lower education (primary and below) (AUC 0.90) compared with those with secondary education and beyond (AUC 0.66).
CONCLUSION: MOCA has high diagnostic utility for major NCD but its usefulness in detecting mild NCD is more modest. Possible reasons include greater heterogeneity in participants with mild NCD and how "quantified clinical assessment" in the DSM-5 mild NCD criteria is interpreted and operationalized.
Copyright © 2015 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DSM-5; Montreal Cognitive Assessment; diagnostic performance; neurocognitive disorder; quantified clinical assessment

Mesh:

Year:  2014        PMID: 25282632     DOI: 10.1016/j.jamda.2014.07.021

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  13 in total

1.  Active case finding of dementia in ambulatory care settings: a comparison of three strategies.

Authors:  T M Liew
Journal:  Eur J Neurol       Date:  2020-06-16       Impact factor: 6.089

2.  Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia.

Authors:  Tau Ming Liew
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 10.668

3.  Use of the EMPOWER brochure to deprescribe sedative-hypnotic drugs in older adults with mild cognitive impairment.

Authors:  Philippe Martin; Cara Tannenbaum
Journal:  BMC Geriatr       Date:  2017-01-31       Impact factor: 3.921

4.  Asymmetry of Hemispheric Network Topology Reveals Dissociable Processes between Functional and Structural Brain Connectome in Community-Living Elders.

Authors:  Yu Sun; Junhua Li; John Suckling; Lei Feng
Journal:  Front Aging Neurosci       Date:  2017-11-03       Impact factor: 5.750

5.  Frequencies of alleles, genotypes and haplotypes of two polymorphisms in the clusterin gene in the Russian elderly population categorized by cognitive performance.

Authors:  Anna V Bocharova; Kseniya V Vagaitseva; Oksana A Makeeva; Andrey V Marusin; Vadim A Stepanov
Journal:  Data Brief       Date:  2017-12-16

6.  'Two-level' measurements of processing speed as cognitive markers in the differential diagnosis of DSM-5 mild neurocognitive disorders (NCD).

Authors:  Hanna Lu; Sandra S M Chan; Linda C W Lam
Journal:  Sci Rep       Date:  2017-03-31       Impact factor: 4.379

7.  Analysis of Association of Genetic Markers in the LUZP2 and FBXO40 Genes with the Normal Variability in Cognitive Performance in the Elderly.

Authors:  Vadim Stepanov; Kseniya Vagaitseva; Anna Bocharova; Andrey Marusin; Valentina Markova; Larisa Minaycheva; Oksana Makeeva
Journal:  Int J Alzheimers Dis       Date:  2018-04-19

8.  What-where-when memory and encoding strategies in healthy aging.

Authors:  Lucy G Cheke
Journal:  Learn Mem       Date:  2016-02-16       Impact factor: 2.460

9.  Effects of horticultural therapy on elderly' health: protocol of a randomized controlled trial.

Authors:  Hui Yu Chan; Roger Chun-Man Ho; Rathi Mahendran; Kheng Siang Ng; Wilson Wai-San Tam; Iris Rawtaer; Chay Hoon Tan; Anis Larbi; Lei Feng; Angelia Sia; Maxel Kian-Wee Ng; Goh Lee Gan; Ee Heok Kua
Journal:  BMC Geriatr       Date:  2017-08-29       Impact factor: 3.921

Review 10.  Mild cognitive impairment history and current procedures in low- and middle-income countries: a brief review.

Authors:  Larissa Hartle; Helenice Charchat-Fichman
Journal:  Dement Neuropsychol       Date:  2021 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.